We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App




Greiner Bio-One Launches Tube Holder for Blood Collection

By LabMedica International staff writers
Posted on 18 Dec 2018
Greiner Bio One International (Kremsmünster, Oberösterreich, Austria) has launched the innovative VACUETTE SAFELINK tube holder with male luer lock that facilitates quick and easy blood collection. More...
The tube offers simple handling and can be used in combination with all medical products that have a standard female luer lock connection, such as winged cannulae.

Greiner Bio-One develops collection systems for human and veterinary samples that make the flow of daily routine tasks in hospitals, laboratories or doctors' surgeries simpler and safer. The company offers sample collection products made out of plastic and also provides custom-made solutions. Greiner Bio-One’s VACUETTE product line is used in hospitals, laboratories, doctors’ offices and blood donor centers in more than 100 countries across the world.

The company has now added VACUETTE SAFELINK tube holder to its product line that comes with a luer lock feature, setting it apart from the conventional Greiner Bio-One tube holders and making it particularly suitable for blood collection from venous access devices according to guideline recommendations (Infusion Therapy Standard of Practice, Revised 2016).

Furthermore, VACUETTE SAFELINK, which is manufactured from unbreakable plastic and does not contain natural rubber latex, offers a secure screw connection between the holder and collection product to ensure safe and successful blood collection. With a controlled threading movement, the single-use product connects safely and smoothly to the respective medical device. Tests have shown that the secure connection can withstand pressures of up to 185mmHg, which combined with its functional design and practical handling, could contribute significantly to increased efficiency in everyday healthcare situations.


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.